iHealthScreen Inc.

iHealthScreen Inc., founded in 2015, is a healthcare technology company that provides innovative health screening solutions for family physicians, community clinics, optometrists, and ophthalmologists for retinal image grading and diagnosis of diseases and screening diseases. iHealthScreen has launched a Regulation A+ offering on StartEngine to raise capital for expanding its business operations. This article aims to look into the investment opportunity presented by iHealthScreen and provide insight into the pros and cons of investing in the company.

Industry Overview

The healthcare industry is one of the largest and most rapidly growing industries globally, driven by demographic shifts, increased awareness of health and wellness, and advances in medical technology. The overall global health screening market was valued at USD 2,11 billion in 2021 and is expected to reach USD 6,09 billion by 2029, registering a CAGR of 12.4% during the forecast period of 2022 to 2029. The key drivers of growth in the health screening market are the rising prevalence of chronic diseases, increasing awareness of preventive healthcare, and growing demand for early disease detection. iHealthScreen's innovative solutions and emphasis on using technology to improve the health screening experience give it a competitive advantage.

Market Opportunity

iHealthScreen's target market is family physicians, community clinics, optometrists, and ophthalmologists. The company's solutions are designed to be convenient, affordable, and accessible to a broad range of customers. iHealthScreen offers a range of health screening services, including retinal image grading and diagnosis of diseases and screening diseases. The company claims to have software for vessel caliber and width measurement, retinal image calibration, retinal central light reflex quantification, focal arteriolar narrowing, and artery-vein nicking quantification, which are significant features for the early detection of Diabetes, hypertension, and Cardiovascular Heart Disease (CVD) and Stroke. The market opportunity for iHealthScreen is significant, given the growing demand for health screening services and the increasing use of technology in healthcare.

Management Team

iHealthScreen's management team has a strong track record in the healthcare and technology industries. The CEO, Alauddin Bhuiyan, has a PhD. in Computer Engineering and more than 15 years of experience in research in medical technology with several patents. The CFO, Thomas Gerson, MBA has over 30 years of experience in finance and joined iHealthScreen in Oct 2022. The team also includes experienced executives in marketing, technology, and operations.

Pros and Cons of Investing

Pros

• iHealthScreen operates in a growing market with significant demand for health screening services.

• The company's innovative solutions and emphasis on using technology to improve the health screening experience give it a competitive advantage.

• The management team has a strong track record of success in healthcare and technology.

Cons

• The health screening market is highly competitive, with established providers such as hospitals and clinics, as well as newer entrants such as telemedicine companies and wellness startups in addition to the existing medical device companies.

• The success of iHealthScreen will depend on its ability to attract and retain customers and compete effectively in the market.

• At this stage, the company is pre-revenue based on its financial disclosure statement. The company has benefited from some national research grants and previous investments.

OUR REQUEST: If you enjoyed reading this edition, make us more motivated by spreading the word! Please share it with your friends or anyone who may be interested in crowdfunding or startups in general. You can use your customized referral link below to let us know that you are the special friend who spread the word - Truly appreciated!

Disclaimer

Fundigogo and its respective employees and affiliates do not provide investment advice or make investment recommendations. The information provided here should not be used as the basis for investment decisions. Readers should conduct their own research and consult with their own investment advisors before making any investment decisions.